| Net income | 409.96M |
| Depletion, depreciation and accretion | |
| Impairment expense | 180.17M |
| Deferred income tax expense | -6.05M |
| Non-cash gain from commodity derivatives | 122.11M |
| Non-cash gain from hedge ineffectiveness | |
| Stock-based compensation | 5.15M |
| Non-cash interest expense | 3.9M |
| Gain on disposition of BBEP Units | |
| Loss from BBEP in excess of cash distributions | |
| Other | |
| Accounts receivable | 35.22M |
| Derivative assets at fair value | |
| Prepaid expenses and other assets | -7.99M |
| Accounts payable | -6.1M |
| Accrued and other liabilities | 58K |
| Net cash provided by operating activities | 111.87M |
| Capital expenditures | -25.01M |
| Proceeds from sale of BBEP Units | |
| Proceeds from sale of properties and equipment | 2.98M |
| Net cash used by investing activities | -22.03M |
| Issuance of debt | 28.34M |
| Repayments of debt | -170.66M |
| Debt issuance costs paid | -80K |
| Gas Purchase Commitment repayments | |
| Issuance of KGS common units - net of offering costs | |
| Distributions paid on KGS common units | |
| Proceeds from exercise of stock options | |
| Taxes paid on vesting of KGS equity compensation | |
| Purchase of treasury stock | |
| Net cash provided by financing activities | -143.95M |
| Effect of exchange rate changes in cash | 6.25M |
| Net increase (decrease) in cash | -47.86M |
| Cash and equivalents at beginning of period | |
| Cash and equivalents at end of period | |